A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-07261-1.pdf
Reference42 articles.
1. Cohen, S. et al. Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis. Arthritis Rheumatol 66, 2924–37 (2014).
2. Souto, A., Maneiro, J. R., Salgado, E., Carmona, L. & Gomez-Reino, J. J. Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. Rheumatology (Oxford) 53, 1872–85 (2014).
3. Winthrop, K. L. et al. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Ann Rheum Dis (2015).
4. Maiga, M. et al. Risk of tuberculosis reactivation with tofacitinib (CP-690550). J Infect Dis 205, 1705–8 (2012).
5. Ashman, R. B. et al. Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol 82, 196–204 (2004).
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Feline gastrointestinal eosinophilic sclerosing fibroplasia associated with Candida albicans;Veterinary Medicine and Science;2024-08-30
2. Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis;PLOS ONE;2024-07-31
3. Discovery of novel dual Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis;Bioorganic & Medicinal Chemistry;2023-12
4. Alopecia Areata: Current Treatments and New Directions;American Journal of Clinical Dermatology;2023-08-22
5. Adverse effect signature extraction and prediction for drugs treating COVID-19;Frontiers in Genetics;2022-11-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3